PMID- 31364177 OWN - NLM STAT- MEDLINE DCOM- 20200513 LR - 20200513 IS - 1558-9307 (Electronic) IS - 0024-4201 (Linking) VI - 54 IP - 10 DP - 2019 Oct TI - Activated PPARbeta/delta Protects Pancreatic beta Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40. PG - 603-616 LID - 10.1002/lipd.12182 [doi] AB - GW501516-activated peroxisome proliferator-activated receptor (PPAR) beta/delta and G-protein-coupled receptor (GPR) 40 were shown to protect pancreatic beta cells against lipoapoptosis. Therefore, this study aimed to investigate whether activated PPARbeta/delta could protect type 2 diabetic rats from lipoapoptosis through regulation of GPR40 and to compare the protective effects of activated PPARbeta/delta and PPARgamma. We made an animal model of type 2 diabetic lipoapoptosis by feeding spontaneously type 2 diabetic Goto-Kakizaki (GK) rats with a high-fat diet (HFD) to evaluate the effects of PPARbeta/delta on islet beta cell apoptosis. And, treated INS-1 cells with 0.5 mM palmitate (PAM) in the absence/presence of GW501516 (a specific agonist of PPAR beta/delta) and with/without transfection of GPR40 siRNA to explore the underlying molecular mechanism. HFD aggravated GK rats' poorer INSR30, lower mass, greater apoptosis of beta cells, lower mass, and lower expression of GPR40, which were similarly improved by GW501516 at 3 or 6 mg/kg day and pioglitazone. Compared with pioglitazone, GW501516 caused more weight loss and had no effect on insulin resistance. GW501516 protected INS-1 cells from PAM-induced apoptosis by upregulating GPR40 and activating Akt/Bcl-2/caspase-3. Activated extracellular regulated protein kinases (ERK) was relevant to the lipoapoptosis in INS-1 cells, but was not involved in the antilipoapoptotic effect of GW501516. These results showed that the PPARbeta/delta agonist GW501516 protected beta cells from lipoapoptosis and improved beta cell mass by upregulating GPR40 and activating the Akt/Bcl-2/caspase-3 pathway, but not the ERK-signaling pathway. CI - (c) 2019 The Authors. Lipids published by Wiley Periodicals, Inc. on behalf of American Oil Chemists' Society. FAU - Li, Juan AU - Li J AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Xu, Shishi AU - Xu S AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Liu, Yuqi AU - Liu Y AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Yan, Zhe AU - Yan Z AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Zhang, Fang AU - Zhang F AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Lv, Qingguo AU - Lv Q AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. FAU - Tong, Nanwei AU - Tong N AD - Department of Endocrinology and Metabolism, West China Hospital of Sichuan University, 37 Guoxuexiang, Chengdu, 610041, China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20190730 PL - United States TA - Lipids JT - Lipids JID - 0060450 RN - 0 (G-protein-coupled receptor 40, rat) RN - 0 (Lipids) RN - 0 (PPAR delta) RN - 0 (PPAR-beta) RN - 0 (Receptors, G-Protein-Coupled) SB - IM MH - Animals MH - *Apoptosis MH - Diabetes Mellitus, Experimental/metabolism/pathology MH - Diabetes Mellitus, Type 2/*metabolism/pathology MH - Disease Models, Animal MH - Insulin-Secreting Cells/*cytology/*metabolism/pathology MH - Lipids/chemistry MH - Male MH - PPAR delta/*metabolism MH - PPAR-beta/*metabolism MH - Rats MH - Rats, Wistar MH - Receptors, G-Protein-Coupled/*metabolism OTO - NOTNLM OT - GK rat OT - GPR40 OT - Lipoapoptosis OT - PPARbeta/delta OT - Pancreatic beta-cell EDAT- 2019/08/01 06:00 MHDA- 2020/05/14 06:00 CRDT- 2019/08/01 06:00 PHST- 2018/07/29 00:00 [received] PHST- 2019/06/17 00:00 [revised] PHST- 2019/07/08 00:00 [accepted] PHST- 2019/08/01 06:00 [pubmed] PHST- 2020/05/14 06:00 [medline] PHST- 2019/08/01 06:00 [entrez] AID - 10.1002/lipd.12182 [doi] PST - ppublish SO - Lipids. 2019 Oct;54(10):603-616. doi: 10.1002/lipd.12182. Epub 2019 Jul 30.